Normal view MARC view ISBD view

Brandi, Giovanni

Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. [electronic resource] - Pancreas Jan 2014 - 53-63 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1536-4828

Standard No.: 10.1097/MPA.0b013e3182a6486e doi

Subjects--Topical Terms:
Angiogenesis Inhibitors--administration & dosage
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Blotting, Western
Cell Line
Cell Line, Tumor
Cell Proliferation--drug effects
Deoxycytidine--administration & dosage
Down-Regulation--drug effects
Drug Evaluation, Preclinical--methods
Enzyme Activation--drug effects
Extracellular Signal-Regulated MAP Kinases--metabolism
Gabexate--administration & dosage
Gene Expression Regulation, Neoplastic--drug effects
Humans
Interleukin-8--genetics
Matrix Metalloproteinase 2--genetics
Matrix Metalloproteinase 9--genetics
NF-kappa B--antagonists & inhibitors
Pancreatic Neoplasms--drug therapy
Proto-Oncogene Proteins c-akt--metabolism
Reverse Transcriptase Polymerase Chain Reaction
Serine Proteinase Inhibitors--administration & dosage
Vascular Endothelial Growth Factor A--genetics
Gemcitabine